shutterstock_1647405886_andrii_yalanskyi
3 November 2020PatentsChristopher Brückner

Supplementary protection certificates: Diverging interests

What impact will Brexit have on supplementary protection certificates (SPCs)? The question is complicated as SPCs are national rights governed by EU Regulations—specifically, Regulation (EC) No 469/2009 of the European Parliament and of the Council of May 6, 2009, concerning the SPC for medicinal products.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Patents
1 January 2012   Advocate-General Verica Trstenjak has delivered an opinion in the case of Neurim Pharmaceuticals that, if followed by the Court of Justice of the EU, will profoundly liberalise the law governing SPCs in Europe.